Violation Tracker Individual Record
Date:November 15, 2012
Offense Group:safety-related offenses
Primary Offense:drug or medical equipment safety violation
GlaxoSmithKline agreed to pay $90 million as part of the settlement of multistate litigation alleging that it engaged in unfair and deceptive practices by misrepresenting the health risks of its diabetes drug Avandia.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:United Kingdom
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.